ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

AACI Recommends Cancer Control Guideline Changes

February 9, 1979

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff

April 16, 1999

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008